AI played key role in designing Moderna's successful skin cancer vaccine
Polymarket · x · 2026-08-20
Moderna and Merck's personalized skin cancer vaccine (mRNA-4157/V940) succeeded in a Phase 3 trial. Reports indicate that AI played a key role in the design process. Polymarket currently gives a 59% chance of FDA approval by the end of 2027.
More from Apps
- Robinhood's new Platinum card includes $250 annual Waymo ride credit — reed · 2026-10-16
- ChatGPT's missing UTM tags confirmed as a bug, traffic attribution fully restored — lilyraynyc · 2026-10-16
- Tolan hailed as the AI product Steve Jobs would have built, per viral essay — ajaymehta · 2026-10-16
- Design Studio Runs Agentic Workflows on FLORA Canvas, From Prototype to Shipped Site — round · 2026-10-16
- AI agents have a 'normal-people problem': most users won't hand over their lives — examachine · 2026-10-16
- She planned a Napa trip with an AI planner, changed everything last minute — 'at least the car drove itself' — katieruthmishra · 2026-10-16